Last Close
Apr 09  •  04:00PM ET
9.83
Dollar change
+0.21
Percentage change
2.18
%
Index
RUT
P/E
-
EPS (ttm)
-6.73
Insider Own
14.45%
Shs Outstand
77.89M
Perf Week
2.72%
Market Cap
766.13M
Forward P/E
3.84
EPS next Y
2.56
Insider Trans
0.08%
Shs Float
66.68M
Perf Month
2.93%
Enterprise Value
2.54B
PEG
0.56
EPS next Q
0.40
Inst Own
96.30%
Perf Quarter
-25.25%
Income
-516.47M
P/S
0.47
EPS this Y
5.35%
Inst Trans
2.72%
Perf Half Y
-31.88%
Sales
1.64B
P/B
0.73
EPS next Y
9.10%
ROA
-13.52%
Perf YTD
-20.85%
Book/sh
13.40
P/C
2.90
EPS next 5Y
6.91%
ROE
-39.90%
52W High
19.25 -48.94%
Perf Year
-48.78%
Cash/sh
3.38
P/FCF
-
EPS past 3/5Y
- -
ROIC
-17.59%
52W Low
8.70 12.99%
Perf 3Y
-82.87%
Dividend Est.
-
EV/EBITDA
8.10
Sales past 3/5Y
1.63% 3.57%
Gross Margin
54.65%
Volatility
4.61% 4.88%
Perf 5Y
-85.98%
Dividend TTM
-
EV/Sales
1.55
EPS Y/Y TTM
-7341.66%
Oper. Margin
9.88%
ATR (14)
0.51
Perf 10Y
-70.02%
Dividend Ex-Date
-
Quick Ratio
1.46
Sales Y/Y TTM
1.53%
Profit Margin
-31.58%
RSI (14)
52.44
Dividend Gr. 3/5Y
- -
Current Ratio
2.54
EPS Q/Q
-108.69%
SMA20
5.65%
Beta
1.05
Payout
-
Debt/Eq
1.95
Sales Q/Q
-1.74%
SMA50
-4.49%
Rel Volume
0.80
Prev Close
9.62
Employees
4427
LT Debt/Eq
1.81
SMA200
-21.83%
Avg Volume
787.57K
Price
9.83
IPO
Aug 16, 1995
Option/Short
Yes / Yes
Trades
Volume
626,632
Change
2.18%
Date Action Analyst Rating Change Price Target Change
Mar-31-25Upgrade Argus Hold → Buy
Dec-02-24Initiated Morgan Stanley Underweight $25 → $20
Oct-07-24Upgrade BTIG Research Sell → Neutral
Jul-30-24Downgrade Citigroup Neutral → Sell $30 → $23
Jul-30-24Downgrade BTIG Research Neutral → Sell $22
May-07-24Downgrade Wells Fargo Overweight → Equal Weight $45 → $25
May-07-24Downgrade Oppenheimer Outperform → Perform
Apr-03-24Upgrade Citigroup Sell → Neutral $38
Dec-05-23Upgrade Wells Fargo Equal Weight → Overweight $40 → $49
Nov-14-23Initiated CL King Buy $50
Apr-07-26 08:30AM
Mar-11-26 05:25AM
Mar-06-26 02:00PM
Mar-02-26 07:41AM
Feb-27-26 09:50AM
05:03PM Loading…
Feb-26-26 05:03PM
04:09PM
03:01PM
09:30AM
08:15AM
06:36AM
06:32AM
06:00AM
Feb-25-26 06:10AM
Feb-23-26 12:00PM
11:34PM Loading…
Feb-19-26 11:34PM
Feb-17-26 08:30AM
Feb-09-26 06:35AM
Jan-23-26 12:22PM
Jan-16-26 09:27AM
Jan-05-26 04:31PM
Jan-04-26 11:02PM
Dec-05-25 11:30AM
Dec-01-25 04:30PM
Nov-25-25 08:30AM
Nov-24-25 01:00PM
Nov-16-25 10:31PM
Nov-13-25 03:05PM
Nov-11-25 04:15PM
Nov-06-25 12:38AM
04:00PM Loading…
Nov-03-25 04:00PM
Oct-31-25 10:20AM
Oct-30-25 04:31PM
01:16PM
09:30AM
07:10AM
06:09AM
06:07AM
06:00AM
Oct-29-25 09:48AM
Oct-28-25 11:11PM
Oct-15-25 02:01PM
08:30AM
Oct-10-25 03:50PM
Oct-08-25 08:30AM
Sep-30-25 12:03AM
Sep-25-25 01:06PM
Sep-22-25 08:30AM
Sep-16-25 10:38AM
Sep-08-25 02:25PM
Aug-29-25 04:30PM
05:06AM
Aug-27-25 11:31PM
Aug-22-25 12:32AM
Aug-21-25 02:55PM
Aug-13-25 12:25AM
12:06AM
Aug-11-25 04:06PM
Jul-31-25 09:30AM
07:10AM
06:28AM
06:06AM
06:00AM
Jul-30-25 09:52AM
Jul-29-25 11:09PM
Jul-14-25 04:35PM
Jul-03-25 09:23AM
Jul-02-25 04:09PM
Jun-26-25 05:47PM
Jun-06-25 11:31AM
Jun-04-25 11:30AM
Jun-03-25 11:37PM
May-30-25 08:32AM
May-28-25 12:01AM
May-06-25 09:04AM
03:03AM
02:14AM
May-05-25 01:54PM
09:30AM
07:40AM
06:39AM
06:30AM
May-02-25 09:25AM
Apr-29-25 09:02AM
Apr-25-25 09:13AM
Apr-18-25 04:30PM
Apr-09-25 08:42AM
Apr-01-25 12:05PM
Mar-27-25 11:30AM
05:01AM
Mar-26-25 08:31AM
Mar-25-25 01:38PM
Mar-24-25 09:13AM
Mar-18-25 09:02AM
Mar-14-25 05:04AM
Mar-13-25 05:00PM
Mar-07-25 08:02AM
Feb-26-25 02:06AM
01:04AM
Feb-25-25 02:07PM
Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. It operates under the Codman Specialty Surgical (CSS) and Tissue Technologies (TT) segments. The CSS segment includes technologies and instrumentation used for neurosurgery, neurocritical care, and otolaryngology. The TT segment focuses on complex wound surgery, surgical reconstruction, and peripheral nerve repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Singh HarvinderEVP & PRESIDENT, INTERNATIONALMar 11 '26Option Exercise0.0018,922040,612Mar 12 06:10 PM
Singh HarvinderEVP & PRESIDENT, INTERNATIONALMar 10 '26Option Exercise0.001,216023,152Mar 12 06:10 PM
Poul MojdehPresident & CEOJan 06 '26Option Exercise0.001,39001,390Jan 07 04:10 PM
GRAVES JEFFREY ADirectorNov 05 '25Buy11.359,000102,15041,086Nov 06 04:05 PM
Singh HarvinderEVP & PRESIDENT, INTERNATIONALOct 12 '25Option Exercise0.0011,965025,217Oct 14 04:28 PM